| http://www.w3.org/ns/prov#value | - Alternative to autologous tumor-loaded DC-based vaccines Crane et al. recently reported their results of a phase I study evaluating feasibility, safety and immunological activities of a 96 kD chaperone heat-shock protein (HSP-96) derived from surgically resected recurrent GBM. Of 28 patients screened, 16 patients did not receive any vaccine, including nine patients from whom inadequate amounts of
|
